ProAssurance Co. (NYSE:PRA - Free Report) - Equities research analysts at Zacks Research increased their Q3 2025 earnings per share estimates for shares of ProAssurance in a note issued to investors on Tuesday, May 27th. Zacks Research analyst K. Dey now expects that the insurance provider will earn $0.30 per share for the quarter, up from their prior estimate of $0.28. The consensus estimate for ProAssurance's current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance's Q4 2025 earnings at $0.25 EPS, Q3 2026 earnings at $0.30 EPS and FY2027 earnings at $1.19 EPS.
ProAssurance (NYSE:PRA - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The insurance provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). The business had revenue of $236.28 million during the quarter, compared to analysts' expectations of $272.85 million. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. The company's revenue was down 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.08 EPS.
PRA has been the topic of a number of other research reports. Wall Street Zen started coverage on ProAssurance in a research note on Monday, May 19th. They set a "hold" rating on the stock. Citizens Jmp cut shares of ProAssurance from an "outperform" rating to a "market perform" rating in a research note on Thursday, April 3rd. Piper Sandler boosted their price objective on shares of ProAssurance from $18.00 to $25.00 and gave the company a "neutral" rating in a research report on Thursday, May 8th. Raymond James lowered shares of ProAssurance from a "market perform" rating to an "underperform" rating in a research report on Thursday, April 10th. Finally, Citigroup downgraded ProAssurance to a "market perform" rating in a report on Thursday, April 3rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, ProAssurance presently has an average rating of "Hold" and a consensus price target of $21.00.
Read Our Latest Analysis on ProAssurance
ProAssurance Price Performance
Shares of NYSE:PRA traded up $0.02 during trading on Thursday, hitting $23.21. 188,028 shares of the stock were exchanged, compared to its average volume of 455,864. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. The company has a fifty day moving average price of $23.15 and a two-hundred day moving average price of $18.45. The company has a market cap of $1.19 billion, a PE ratio of 27.96 and a beta of 0.04. ProAssurance has a 12-month low of $10.76 and a 12-month high of $23.70.
Hedge Funds Weigh In On ProAssurance
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Sterling Capital Management LLC lifted its position in ProAssurance by 859.4% in the fourth quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider's stock worth $26,000 after purchasing an additional 1,461 shares during the period. Quantbot Technologies LP acquired a new position in shares of ProAssurance during the 1st quarter valued at $47,000. GAMMA Investing LLC raised its stake in shares of ProAssurance by 307.3% in the 1st quarter. GAMMA Investing LLC now owns 2,073 shares of the insurance provider's stock worth $48,000 after buying an additional 1,564 shares in the last quarter. CWM LLC lifted its holdings in shares of ProAssurance by 95.9% in the first quarter. CWM LLC now owns 2,204 shares of the insurance provider's stock valued at $51,000 after buying an additional 1,079 shares during the period. Finally, KBC Group NV grew its position in ProAssurance by 75.4% in the fourth quarter. KBC Group NV now owns 4,184 shares of the insurance provider's stock worth $67,000 after buying an additional 1,798 shares during the last quarter. Institutional investors own 85.58% of the company's stock.
About ProAssurance
(
Get Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Articles
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
